Medical Properties Trust, Inc. (MPW) Financial Ratios
22 years of historical data (2004–2025) · Real Estate · REIT - Healthcare Facilities
EV/EBITDA
↑
105.41
↑+241% vs avg
5yr avg: 30.90
30Y Low11.8·High92.3
P/FCF
↓
14.62
↑+24% vs avg
5yr avg: 11.79
30Y Low5.8·High18.7
P/B Ratio
↓
0.74
-7% vs avg
5yr avg: 0.79
30Y Low0.4·High1.8
ROE
↓
-4.2%
↓+32% vs avg
5yr avg: -6.2%
30Y Low-39%·High24%
Debt/EBITDA
↓
4.57
↓-50% vs avg
5yr avg: 9.18
30Y Low4.4·High14.7
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
MPW Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Medical Properties Trust, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 14.6x P/FCF, 24% above the 5-year average of 11.8x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $3.4B | $3.0B | $2.4B | $2.9B | $6.7B | $13.9B | $11.6B | $9.0B | $5.9B | $4.8B | $3.2B |
| Enterprise Value | $3.0B | $2.6B | $11.0B | $12.9B | $16.8B | $24.9B | $20.0B | $14.7B | $9.1B | $9.6B | $6.1B |
| P/E Ratio → | -17.12 | — | — | — | 7.43 | 21.29 | 26.90 | 24.26 | 5.83 | 16.80 | 14.30 |
| P/S Ratio | 3.47 | 3.09 | 2.38 | 3.37 | 4.32 | 9.03 | 9.25 | 10.39 | 7.51 | 6.85 | 5.93 |
| P/B Ratio | 0.74 | 0.65 | 0.49 | 0.38 | 0.78 | 1.65 | 1.57 | 1.29 | 1.29 | 1.26 | 0.99 |
| P/FCF | 14.62 | 13.02 | 9.66 | 5.81 | — | 18.69 | — | — | — | — | 10.99 |
| P/OCF | 14.62 | 13.02 | 9.66 | 5.81 | 9.03 | 17.18 | 18.71 | 18.30 | 13.11 | 13.30 | 12.13 |
P/E links to full P/E history page with 30-year chart
MPW EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Medical Properties Trust, Inc.'s enterprise value stands at 105.4x EBITDA, 241% above its 5-year average of 30.9x. The Real Estate sector median is 16.7x, placing the stock at a 531% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.67 | 11.07 | 14.81 | 10.92 | 16.09 | 16.02 | 16.88 | 11.64 | 13.64 | 11.21 |
| EV / EBITDA | 105.41 | 92.28 | 13.11 | 18.51 | 12.49 | 18.11 | 18.13 | 16.20 | 13.00 | 15.57 | 13.81 |
| EV / EBIT | — | — | 28.48 | 158.82 | 16.79 | 23.93 | 24.16 | 24.58 | 16.28 | 18.66 | 16.02 |
| EV / FCF | — | 11.23 | 44.88 | 25.52 | — | 33.32 | — | — | — | — | 20.76 |
MPW Profitability
Margins and return-on-capital ratios measuring operating efficiency
Operating margins have expanded from 9.3% to 38.9% over the past 3 years, signaling improving operational efficiency. A negative ROE of -4.2% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | 97.3% | 95.2% | 97.0% | 97.5% | 98.0% | 97.2% | 98.8% | 99.2% | 99.5% |
| Operating Margin | — | — | 38.9% | 9.3% | 65.1% | 67.2% | — | 86.2% | 71.5% | 68.9% | 63.1% |
| Net Profit Margin | -20.4% | -20.4% | -242.1% | -63.8% | 58.5% | 42.5% | 34.5% | 43.1% | 129.6% | 41.1% | 41.6% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -4.2% | -4.2% | -38.7% | -6.9% | 10.6% | 8.3% | 6.0% | 6.5% | 24.2% | 8.2% | 8.4% |
| ROA | -1.4% | -1.4% | -14.8% | -2.9% | 4.5% | 3.5% | 2.8% | 3.2% | 11.4% | 3.8% | 3.7% |
| ROIC | — | — | 1.9% | 0.3% | 3.9% | 4.4% | — | 5.5% | 5.1% | 4.9% | 4.5% |
| ROCE | — | — | 2.6% | 0.5% | 5.3% | 5.7% | — | 6.6% | 6.4% | 6.5% | 5.9% |
MPW Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Medical Properties Trust, Inc. carries a Debt/EBITDA ratio of 4.6x, which is highly leveraged (42% below the sector average of 7.9x). The company holds a net cash position — cash of $541M exceeds total debt of $128M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.03 | 0.03 | 1.86 | 1.34 | 1.21 | 1.35 | 1.23 | 1.01 | 0.89 | 1.29 | 0.90 |
| Debt / EBITDA | 4.57 | 4.57 | 10.68 | 14.66 | 7.72 | 8.29 | 8.16 | 7.84 | 5.78 | 8.02 | 6.69 |
| Net Debt / Equity | — | -0.09 | 1.79 | 1.31 | 1.18 | 1.29 | 1.15 | 0.80 | 0.71 | 1.25 | 0.88 |
| Net Debt / EBITDA | -14.69 | -14.69 | 10.28 | 14.30 | 7.54 | 7.95 | 7.66 | 6.23 | 4.62 | 7.75 | 6.50 |
| Debt / FCF | — | -1.79 | 35.22 | 19.71 | — | 14.63 | — | — | — | — | 9.77 |
| Interest Coverage | — | — | 0.92 | 0.20 | 2.72 | 2.63 | — | 3.15 | 2.51 | 2.74 | 2.14 |
Net cash position: cash ($541M) exceeds total debt ($128M)
MPW Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Medical Properties Trust, Inc.'s current ratio of 9.77x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 0.71x to 9.77x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.77 | 9.77 | 1.55 | 0.71 | 1.09 | 7.49 | 9.20 | 15.48 | 4.90 | 1.90 | 1.13 |
| Quick Ratio | 9.77 | 9.77 | 1.55 | 0.71 | 1.09 | 7.49 | 9.20 | 15.48 | 5.19 | 2.14 | 1.33 |
| Cash Ratio | 3.66 | 3.66 | 0.39 | 0.13 | 0.15 | 0.76 | 1.25 | 5.02 | 3.77 | 0.75 | 0.37 |
| Asset Turnover | — | 0.06 | 0.07 | 0.05 | 0.08 | 0.08 | 0.07 | 0.06 | 0.09 | 0.08 | 0.08 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
MPW Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Medical Properties Trust, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | 13.5% | 20.9% | 10.5% | 4.6% | 4.9% | 4.6% | 6.2% | 6.8% | 6.8% |
| Payout Ratio | — | — | — | — | 77.4% | 98.1% | 131.6% | 109.9% | 35.8% | 112.7% | 97.0% |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | 13.5% | 4.7% | 3.7% | 4.1% | 17.2% | 6.0% | 7.0% |
| FCF Yield | 6.8% | 7.7% | 10.4% | 17.2% | — | 5.4% | — | — | — | — | 9.1% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 13.5% | 20.9% | 10.7% | 4.6% | 4.9% | 4.6% | 6.2% | 6.8% | 6.8% |
| Shares Outstanding | — | $601M | $600M | $599M | $599M | $590M | $530M | $428M | $366M | $350M | $261M |
Peer Comparison
Compare MPW with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 MPWYou | $3B | -17.1 | 105.4 | 14.6 | — | — | -4.2% | — | 4.6 |
 GMRE | $94M | 115.3 | 8.3 | — | 78.9% | 23.6% | 1.1% | 2.0% | 7.4 |
 HR | $7B | -28.5 | 17.0 | 55.6 | -33.6% | 8.0% | -4.9% | 0.7% | 6.3 |
 OHI | $14B | 23.7 | 16.7 | 15.6 | 44.5% | 62.6% | 11.6% | 6.0% | 4.0 |
 SBRA | $5B | 32.0 | 17.0 | 14.8 | 65.0% | 34.1% | 5.6% | 3.8% | 5.7 |
 LTC | $2B | 15.3 | 10.1 | 13.7 | 96.9% | 79.4% | 10.7% | 8.9% | 2.6 |
 CHCT | $500M | 226.2 | 16.2 | 8.9 | 8.7% | 16.7% | 1.1% | 1.6% | 8.4 |
 VTR | $41B | 160.4 | 24.3 | 31.3 | -5.9% | 14.2% | 2.1% | 2.5% | 6.0 |
 WELL | $152B | 155.7 | 67.4 | 53.3 | 39.2% | 3.3% | 2.5% | 0.5% | 8.6 |
 NHI | $4B | 24.5 | 17.0 | 16.3 | 36.7% | 51.5% | 9.7% | 5.6% | 4.2 |
 DOC | $14B | 195.0 | 14.6 | 11.8 | 22.5% | 19.3% | 0.8% | 2.3% | 6.5 |
| Real Estate Median | — | 24.5 | 16.7 | 15.6 | 52.1% | 26.0% | 3.5% | 3.0% | 7.9 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 22 years · Updated daily
See MPW's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MPW Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MPW vs GMRE
Side-by-side business, growth, and profitability comparison vs Global Medical REIT Inc..
Start ComparisonMPW — Frequently Asked Questions
Quick answers to the most common questions about buying MPW stock.
What is Medical Properties Trust, Inc.'s P/E ratio?
Medical Properties Trust, Inc.'s current P/E ratio is -17.1x. The historical average is 22.1x.
What is Medical Properties Trust, Inc.'s EV/EBITDA?
Medical Properties Trust, Inc.'s current EV/EBITDA is 105.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 19.8x.
What is Medical Properties Trust, Inc.'s ROE?
Medical Properties Trust, Inc.'s return on equity (ROE) is -4.2%. The historical average is 4.4%.
Is MPW stock overvalued?
Based on historical data, Medical Properties Trust, Inc. is trading at a P/E of -17.1x. Compare with industry peers and growth rates for a complete picture.
How much debt does Medical Properties Trust, Inc. have?
Medical Properties Trust, Inc.'s Debt/EBITDA ratio is 4.6x, indicating high leverage. A ratio above 4x may signal elevated financial risk.